The American Board of Pathology Announces the Appointment of Bradley Ford, M.D. Ph.D. to the Test Development and Advisory Committee for Medical Microbiology

Dr. Bradley FordThe American Board of Pathology (ABPath) is pleased to announce the appointment of  Bradley Ford, M.D. Ph.D, to the ABPath’s Test Development and Advisory Committee (TDAC) for Medical Microbiology beginning in 2024. The TDACs are responsible for developing and reviewing the ABPath certification exam questions that assess and certify a physician’s education, knowledge, experience, and skills in order to provide high-quality care in pathology.

Membership in a TDAC is by invitation only and there are only seven members of the Medical Microbiology TDAC.  To be appointed to a TDAC means a physician is an established subject matter expert in their subspecialty field and is current on the latest advances in the continually evolving field of pathology and patient care. TDAC committee members develop and review examination questions for statistical performance and relevance to current practice. They contribute to the validity of examinations by determining the content and distribution of items on examinations (exam blueprints).  The TDACs also advise the ABPath on issues in their subspecialty area of expertise.

“The members of our Test Development and Advisory committees are experts in their respective fields.  These individuals are instrumental in assessment development, the setting of standards, and provide guidance regarding the current state of Pathology.  The appointment of an individual to a test committee is a recognition of their expertise and their contributions ensures the integrity and relevance of board certification,” states Gary W. Procop, MD, CEO of the American Board of Pathology.

Friday, February 16, 2024